A foreign-body-type host response can contribute to the induction and release of collagenolytic tissue-destructive enzymes of pathogenetic significance. Our aim was to analyse collagenase-3 in two conditions with putative involvement of foreign-body reactions. Synovial membrane-like tissue samples were obtained from cases of aseptic loosening of a total hip replacement (THR) and osteoarthritis (OA).
Foreign bodies may be exogenous such as implant-derived material, or ectopic such as pieces of articular cartilage or calcium pyrophosphate dihydrate (CPPD) crystals embedded in synovial membrane, and their presence can lead to chronic inflammation. This inflammatory host response can become chronic if the particles are not easily degraded, non-degradable or produced in excess. Examples include metal alloy particles 1 or polymers such as polyethylene 2, 3 or methacrylate 4 as are seen in the synovial-membrane-like interface tissue 5 in aseptic loosening of a total hip replacement (THR), and pieces of hyaline articular cartilage 6, 7 or CPPD and basic calcium phosphate [8] [9] [10] crystals found in the synovial membrane in osteoarthritis (OA). They are often very large and cause production and secretion of neutral endoproteinases to assist in degradation at the pH prevailing in the extracellular mileau. When excessive, this induction and release of proteolytic enzymes into the extracellular space may contribute to the aseptic loosening of the implant 11, 12 or acceleration of the degradation of the hyaline articular cartilage. 13, 14 The main extracellular matrix macromolecules responsible for the mechanical strength of the connective tissue are the interstitial collagens. They are characterised by a (Gly-X-Y) n repeat sequence where X is often proline and Y is often hydroxyproline or hydroxylysine. This primary structure allows organisation into typical triple helical coiledcoil collagen monomers which are further organised into supramolecular collagen fibres. They give the collagen molecules a high tensile strength and a resistance to the action of non-specific proteolytic enzymes. Interstitial collagenases are the only mammalian enzymes which can cleave the triple helix of the collagen monomer at 775 Ile(Leu). They contain the so-called fibroblast collagenase or MMP-1 and the neutrophil collagenase or MMP-8. In 1994, a new member of this enzyme family was described in human breast cancer, 15 and was subsequently named collagenase-3 or MMP-13. In 1996 it was found in chondrocytes 16, 17 and as an mRNA in synovial membrane in osteoarthritis (OA). 18 More recently, we have demonstrated a high expression of collagenase-3 also in the synovial membrane of patients with rheumatoid arthritis (RA). 19 The substrate profile of the new collagenase-3 favours type-II collagen over type I and type III although they are also effectively degraded. 20 Collagenase-3 is also active against aggrecan, the major proteoglycan of the hyaline articular cartilage, 21 and may therefore play a significant pathogenetic role in both OA and aseptic loosening of a THR. OA is a disease characterised primarily by destructive changes and loss of the hyaline articular cartilage with secondary inflammatory changes in the synovial membrane. 22 Aseptic loosening is characterised by inflammatory changes 23 in the synovial-membrane-like interface tissue 5 between the implant and bone around the loosening implant. This is probably caused by implant-derived particles, which lead to local production of collagenolytic enzymes. 24 They can weaken the periprosthetic tissue and process the osteoid-covered bone surface for osteoclast attachment. 24, 25 Our aim was to analyse collagenase-3 in samples from primary and revision THR and from 'control' samples of synovial membrane.
Materials and Methods
We obtained tissue specimens consisting of synovial-membrane-like tissue from the bone-prosthesis interface on the femoral stem of 13 patients with OA at the time of revision for clinical failure of a THR. All the patients had radiological and clinical evidence of prosthetic loosening. Patients with RA or malignancy were excluded. The diagnosis of OA had been based on characteristic clinical and radiological features. The mean age of the patients was 70.5 years (44 to 85) and the mean time between the primary and revision THR was 8.7 years (1 to 17) (Table I) .
For comparison, samples of synovial membrane were obtained from ten patients with OA undergoing primary THR and from ten having diagnostic/therapeutic arthroscopy. The last group consisted of three patients with meniscal injury, two with habitual dislocation of the patella, one with injury to the collateral ligament, three with injury to the anterior cruciate ligament and one with knee pain and no other significant findings; no patient had evidence of recent or past haemorrhage. These samples represent our control group and a more detailed description of their histology is given in Table II which shows that they were not totally non-inflammatory. All the tissue specimens were embedded and frozen in optimal compound for tissue embedding (Lab-TeK Products, Indiana) immediately after sample collection and stored at -70°C until further processing.
In addition to the tissue samples, we obtained synovial fluid from the hips of five patients undergoing primary THR for OA and from five having revision THR for aseptic After the first strand synthesis the beads were collected with a magnet, resuspended in 50 l of distilled water and heated at +95°C for 1 minute. They were then collected using the magnet and the supernatant containing mRNA was pipetted off. Target-specific primers were designed according to advice from Dr M. Balbin 20 corresponding to the bases 572-593 for 5' (5'-CCT CCT GGG CCA AAT TAT GGA G-3') and 944-964 bases for 3' (5'-CAG CTC CGC ATC AAC CTG CTG-3') oligonucleotide primers. The beads were washed once with 50 l of PCR buffer (10 mM Tris-HC1, pH 8.8, 1.5 mM MgC1 2 , 50 mM KC1, 0.1% Triton X-100) and the PCR reaction was performed in PCR buffer containing 5' primer (0.17 M final) and 100 M of dATP, dCTP, dGTP and dTTP in a total volume of 30l topped with 50 l of mineral oil. To this was added 0.5 U of the thermostable DNA polymerase (Finnzymes, Espoo, Finland) and the samples were denatured at +95°C for two minutes and annealed at +68°C for one minute followed by five-minute extension at +72°C with mixing at one-minute intervals. After melting the strands for two minutes at +95°C the beads were collected with the magnet, and the second strand cDNA supernatant was transferred to a new PCR tube where the 3' primer (0.17 M final) was pipetted. We performed 40 cycles of one minute at +95°C, one minute at +68°C and one minute at +72°C and an eight-minute extension was used for the last cycle. Amplified DNA was run in a 1% modified agarose gel (FMC Bioproducts, Rockland, Maine) for size verification. For positive identification DNA was extracted from the gel using a QIAquick gel extraction kit (Qiagen Inc, Chatsworth, California) and quantified spectrophotometrically. Approximately 100 ng/DNA fragments were sequenced using fluoroscein-labelled dye terminator kits supplied by ABI (PE Applied Biosystems, Foster City, California) and analysed on an Applied Biosystems automatic sequencer 373 A (PE Applied Biosystems). Breast cancer mRNA transcripts were used as a positive control. PCRs done without template and also without both template and primers were used as a negative PCR control. Extraction of mRNA was controlled using primers for ␤-actin and amplification of mRNA transcripts was certified by comparing the mRNA template sequence (393 bp) with the corresponding genomic DNA sequence (4993 bp; unpublished data from Dr C. Lopéz-Otín).
Preparation of the rabbit anti-human collagenase-3 immunoglobulin G (IgG). Recombinant human collagenase-3 was produced in E.coli and 8M urea was used to solubilise the insoluble fraction of the cell lysate. 8M urea extract (1 ml) was electrophoresed through a 12% polyacrylamide gel and the portion of the gel containing the recombinant protein was excised, grounded and incubated with 2 ml of deionised water at +37°C for about 20 hours with sporadic vortexing. SDS-PAGE-purified protein (1 ml) was used to immunise a New Zealand White rabbit. It was bled six weeks after the injection and the IgGs were purified by chromatography through a DEAE-cellulose column (Whatman DE52) equilibrated and eluted with 20 mM phosphate buffer, pH 7.2. The IgG concentration was 1 g/ l. Preliminary experiments directed to examine possible cross-reactivity with other MMPs including fibroblast collagenase (collagenase-1 or MMP-1), neutrophil collagenase (collagenase-2 or MMP-8) and stromelysins (stromelysin-1 or MMP-3, stromelysin-2 or MMP-10 and stromelysin-3 or MMP-11) failed to show any significant cross-reactivity. Immunohistochemistry for collagenase-3. Cryostat sections (6 m) were mounted on gelatin-formalin-coated glass slides and fixed in acetone for five minutes at +4°C. Endogenous peroxidase activity was inhibited with 0.4% H 2 O 2 in 0.01 M phosphate-buffered saline (PBS, pH 7.4) for 30 minutes. Sections were rinsed in 0.3% Triton X-100 in 0.1 M PBS before staining using the avidin-biotin-peroxidase complex (ABC) method. Serial sections were sequentially incubated with: 1) normal rabbit serum (1:20; Vector Laboratory, Burlingame, California) for 20 minutes at room temperature; 2) rabbit anti-human collagenase-3 IgG (1:150) for overnight at +4°C; 3) biotinylated horse anti-rabbit IgG for one hour at +22°C; 4) ABC complexes in 0.1 M PBS (1:100; Vector Laboratory) for one hour at +22°C; and 5) 0.06% 3,3'-dia-minobenzidine tetrahydrochloride (DAB; Sigma Chemicals, St Louis, Missouri) and 0.006% H 2 O 2 . Half of the stained sections were counterstained with haematoxylin. All sections were dehydrated in an ethanol series, cleared in xylene and placed under cover slips in synthetic medium. Replacement of the primary antibodies with normal rabbit IgG was used as a negative staining control. In addition, an antigen preabsorption control was carried out. Briefly, 6 g of recombinant human collagenase-3 was used to provide approximately 20-fold excess of antigen over IgG-binding sites. Antigen preabsorption controls were negative and thus confirmed the specificity of the immunohistochemical staining results.
Double immunohistochemistry for collagenase-3 and CD68 or prolyl 4-hydroxylase. To confirm the cellular sources of collagenase-3 another series of sections from the same patients was stained for CD68, a cell-surface marker of macrophage/monocyte lineage, 26 and for prolyl 4-hydroxylase, a constitutive intracellular enzyme of fibroblasts. 27, 28 The monoclonal 5B5 mouse anti-human prolyl 4-hydroxylase recognises the ␤ subunit of the heterotetrameric prolyl 4-hydroxylase enzyme, which is expressed in fibroblasts in normal and inflamed tissues, but was not observed in lymphocytes, monocytes, dendritic cells or granulocytes. 28 In addition, it stains cells actively involved in protein synthesis, such as plasma cells and acinar cells, 29 probably because it also recognises the ␤ subunit as part of the homodimeric disulphideisomerase, which is involved in the SS-SH interchange reactions/ protein folding. 30 Sections were first stained for collagenase-3 using ABC staining, and then for CD68 and prolyl 4-hydroxylase using alkaline phosphate and the mouse monoclonal anti-alkaline phosphatase (APAAP) method. Briefly, the sections stained from collagenase-3 were further incubated with: 1) mouse anti-human CD68 ( Electrophoresis and protein blotting. Synovial fluid was diluted 1:10 with 20 mM Tris-HC1 and 150 mM NaC1 at pH 7.4. After addition of the sample buffer (one part sample, two parts buffer), the samples were heated at +100°C for five minutes. The sample buffer was 200 mM Tris-HC1, pH 8.8, 6% SDS, 20% glycerol, 0.004% bromphenol blue and 0.5% 2-mercaptoethanol; 10 l were loaded per lane. Low-range prestained standard (Bio-Rad, Richmond, California) was used as a molecular-weight marker. The samples were separated on 12% SDS-PAGE cross-linked gels at 200 V for 30 to 45 minutes and electrophoretically transferred to 0.45 m nitrocellulose mem- Figure 5D -Photomicrograph of a counterstained serial section to that shown in Figure 5C showing the perivascular lymphocyte infiltrate (haematoxylin counterstaining ‫.)052ן‬
branes at 100 V for 45 minutes using a mini-gel system (Bio-Rad).
Immunological detection of the blotted MMPs. We used 3% bovine serum albumin in 20 mM Tris-HC1, 150 mM NaC1, pH 7.4, 0.05% Triton X-100 (TTBS) to block nonspecific binding sites on the nitrocellulose membrane. After three 15-minute washes with TTBS the membranes were incubated in rabbit anti-human collagenase-3 IgG (1:500) for 12 hours. After three 15-minute washes with TTBS the binding sites were visualised using the ABC method. DAB and H 2 O 2 were used as chromogen substrates. All incubations were carried out at +22°C.
Results
Collagenase-3 mRNA in the synovial membrane samples of OA, aseptic loosening and controls. RT-PCR analysis showed the presence of collagenase-3 mRNA consistently in all samples of aseptic loosening obtained from revision THRs (Fig. 1 ) and all samples obtained for primary THRs for OA (Fig. 2) . This was in clear contrast to its presence in only a fraction (3/10, controls 4c, 5c and 7c) of samples of control synovial membrane obtained from nonarthritic knees (Fig. 3) . The control samples containing collagenase-3 mRNA in the RT-PCR assay were also those with the most marked inflammation seen histopathologically (Table II) . All the experiments were repeated at least twice with consistent results. Nucleotide sequencing of the PCR amplification products was used to confirm the identity of the amplified bands. Collagenase-3 immunoreactivity in OA synovium. The synovial membrane of the osteoarthritic patients showed two distinctive patterns. There was a nearly normal synovium with a lining cell layer only one or two cell layers thick covering apparently non-inflamed subsynovial loose connective tissue. In addition, there were slightly inflamed areas with a synovial lining consisting of multiple cell layers above sublining tissue containing increased numbers of macrophage-and fibroblast-like stromal cells and perivascular lymphocyte-rich cell infiltrates. The multiple synovial lining cells and the macrophageand fibroblast-like cells below it were strongly immunoreactive to collagenase-3 (Fig. 4A) . Single lining showed immunoreactivity to collagenase-3, but there were rela-tively few weakly immunoreactive collagenase-3 cells in the lining and sublining tissues (Fig. 4B) . The endothelial cells of the blood vessels in the inflammatory osteoarthritic synovium were strongly collagenase-3-positive (Fig. 4C ) whereas in non-involved areas they were less so (Fig. 4D) . Similarly, control synovial tissue from patients with knee injury had relatively few weakly-staining collagenase-3-positive cells (Fig. 4E) . Staining controls confirmed the specificity of the staining (Fig. 4F) .
The aggregated sublining cells contained a number of multinucleated giant cells presumably formed in response to cartilage debris, microcrystals or osteophyte fragments. These giant cells were strongly immunoreactive to collagenase-3 (Fig. 5A) . One specimen had a relatively large piece of bone debris in which most of the osteocyte cavities were empty as a result of osteocyte necrosis. The few still viable osteocytes had strong immunoreactivity to collagenase-3 (Fig. 5B) . Lymphocyte aggregates were not immunoreactive to collagenase-3 ( Figs 5C and 5D ). Collagenase-3 immunoreactivity in synovial membranelike interface tissue of loosened THRs. The marginal portion of the interface membrane was covered by a lining cell layer which had a similar morphological diversity to that seen in the osteoarthritic synovium: the composition varied from single-cell to multiple-cell layers. Usually, it was two to three cell layers thick and the sublining tissue below was relatively cell-rich, mostly composed of macrophage-and fibroblast-like cells with occasional sublining lymphocyte aggregates. The multiple lining and the sublining cells were strongly immunoreactive to collagenase-3 ( Fig. 6A) , while the single-cell lining synovium was weakly reactive (Fig. 6B) . The extracellular space in the sublining tissue often contained metal debris and amorphous material of either methylmethacrylate or polyethylene as determined by polarised light. The presence of debris did not necessarily coincide with the expression of collagenase-3 by interstitial cells (Figs 6C and 6D ) and vice versa. Collagenase-3 was often expressed in areas with no evidence of foreign particles (data not given) as assessed by routine light microscopy and in polarised light. Double immunohistochemistry for collagenase-3 and CD68 or prolyl 4-hydroxylase. Endothelial cells immunoreactive for collagenase-3 were easy to recognise based on their typical histological characteristics and organisation ABC staining of collagenase-3 in the synovial membrane-like interface tissue from a THR with aseptic loosening. Figure 6A -The synovial membrane-like interface tissue shows a strong expression of collagenase-3 in the synovial lining consisting of multiple cell layers and in the sublining macrophage-and fibroblast-like cells. Figure 6B -The single lining of the synovial membrane-like interface tissue shows faint immunoreactivity to collagenase-3 and the sublining space contains relatively few collagenase-3 immunoreactive cells. Figure 6C -Sublining tissue containing metal debris from a TiA1V prosthetic stem which has induced collagenase-3 expression in the macrophage-and fibroblast-like interstitial cells. Figure 6D -A serial section to that shown in Figure 6C . The haematoxylin counterstain clearly shows many macrophage-and fibroblast-like cells in the area of the deposition of metal debris ‫.)004ן(‬ and were therefore not subjected to a double-staining procedure. Double staining showed prolyl 4-hydroxylase immunoreactive fibroblast-like cells (Figs 7A and 7B) and CD68-immunoreactive macrophage-like cells (Figs 7C and 7D) as additional cellular sources of collagenase-3. Collagenase-3 in the synovial fluid. All synovial fluid samples from primary THRs performed for OA and from revision THRs performed for aseptic loosening contained a typical 60/50 kD MMP-13 duplex band, which probably represents the proenzyme and the proteolytically-activated MMP-13 enzyme species, respectively (Fig. 8) .
Discussion
We have attempted to characterise the osteoarthritic synovia and the interface membrane of loosened THRs in terms of collagenase-3 expression. Collagenase-3 has been described in breast cancer tissue 15 and more recently in chondrocytes 16, 17 and synovial membrane, 19 but not in osteoarthritic synovium or similar tissue developing between the implant and bone in aseptic loosening of totally replaced joints. In OA, the strong expression seen in samples with a multiple synovial lining clearly contrasted with the faint or no expression in the single synovial lining and sublining tissue of control synovial membrane samples and even in areas of the OA samples which showed no signs of inflammation such as intimal hyperplasia or inflammatory cell infiltrates. The synovial-membrane-like interface tissue had a similar distribution and extent of collagenase-3 expression. These findings suggest that not only malignantly transformed breast cancer cells, but also cells of a non-malignant phenotype can be induced to express collagenase-3. Such cells include fibroblasts/fibroblast-like type-B lining cells, macrophages/macrophage-like type-A lining cells and endothelial cells. The very restricted site-specific expression of collagenase-3, tested using an extensive panel of tissue samples, 15 suggests that its synthesis is normally strictly regulated and may relate to its potential tissue-destructive property which, according to our study, is released in OA and in aseptic loosening of a THR. Indeed, due to its substrate profile 20, 21 collagenase-3 has a significant potential to augment the key pathogenetic processes in these two diseases, namely enzymatic degradation of the hyaline articular cartilage in OA 22 and degradation of the collagenous interface tissue 24 in aseptic loosening of a THR.
Particulate stimuli have been shown to be able to induce various collagenases, but to what extent this is a direct or indirect effect is not known. 31 By contrast, various growth factors and cytokines, alone or in various combinations, have been shown to increase the production of many of the MMPs. 32 Implant-derived particles have been described as co-localising with various locally produced cytokines/ growth factors, 33 but collagenase-3 expression did not colocalise with the implant-derived debris. This distinctive topological pattern of collagenase-3 distribution implies a paracrine manner of regulation. MMPs, which are neutral endoproteinases active at the pH prevailing in the extracellular matrix (but in the acidic intracellular phagolysosomes), are not stored in the synthesising cells. There are two exceptions: collagenase-2 (or MMP-8, also known as 'neutrophil collagenase') which is synthesised during the myelocyte stage of the development of the neutrophils, stored in the specific or secondary granules and released first upon activation of the cells; and the newly-discovered membrane-type MMPs (MMP-14 to MMP-18; e.g. MT1-MMP or MMP-14) which are integral membrane cell (glyco)proteins. There is every reason to believe therefore that MMP-13, if synthesised, is also secreted into the extracellular mileau. Accordingly, we found MMP-13 in the synovial fluid from all patient samples. Based on the apparent molecular weight of the synovial fluid MMP-13, we concluded that it was not complexed with its endogenous inhibitors, namely tissue inhibitors of metalloproteinases (TIMPs). This may be relevant in tissue destruction, e.g. of hyaline articular cartilage and interface tissues. All enzymes known to act as specific collagenases at present (i.e., collagenase-1 or MMP-1 or 'fibroblast' collagenase, collagenase-2 or MMP-8, having the 'neutrophil' and the less glycosylated 'mesenchymal' isoforms, and collagenase-3 or MMP-13) cleave at a single specific initial cleavage site, namely 775 Gly-776 Ile(Leu). For the newly-described 72 kD gelatinase/type-IV collagenase (gelatinase A) or MMP-2 and for the MT1-MMP or MMP-14, the specific cleavage site has not yet been confirmed although it seems that the typical 3/4-and 1/4-cleavage products are also produced. We have previously shown that such collagenolytic activity is found in samples obtained from aseptic loosening of a THR. 24, 34 Future studies with collagenase-inhibiting drugs displaying different inhibitory profiles may help to determine which of the collagenases is mainly responsible for the local activity. 35, 36 The aetiology and pathogenesis of OA and aseptic loosening are not known, but collagenase-mediated tissue destruction has been suggested to have a role in both. It is also not known at present what causes the induction and/or release of collagenases in these two conditions. 22, 24 Based on the similar cellular profile and extent of expression, it is suggested that the induction of MMPs may in part relate to and be accentuated by the production of microcrystals and/ or debris from hyaline articular cartilage in OA [6] [7] [8] [9] [10] and from implants in aseptic loosening. [1] [2] [3] [4] This level of expression, at the mRNA and enzyme protein level, was clearly higher than was seen in almost normal control synovial membrane samples from patients with knee injury, but consistently lower than we have previously described using immunohistochemistry in RA synovium. 19 The presence of 'foreign' particles seems to be the most obvious common denominator in these two conditions. The interface membrane has been regarded as granulomatous tissue formed as a response against prosthesis-wear debris. 37 This type of secondary inflammatory foreign-body host response has also been suggested to play an important role in OA. 22 In any event, the production of collagenase-3 may augment the destructive events in local tissue and, by a vicious circle, contribute to the further release of particles, which may in part be responsible for tissue destruction and some of the major clinical symptoms and signs in these two conditions.
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